Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
A tissue culture for non-neoplastic disorders, as described by CPT® Code 88235, involves the cultivation of amniotic fluid or chorionic villus cells. This procedure is essential for conducting a chromosome analysis that is separately reportable and specifically targets non-neoplastic disorders. Non-neoplastic disorders encompass a range of genetic conditions that do not involve tumors but can lead to significant congenital anomalies or other health issues. Examples of these disorders include sister chromatid exchange (SCE), breakage syndromes, trisomies, and mosaicism. The process begins with the collection of amniotic fluid or chorionic villus samples, which are critical for obtaining the necessary cells for analysis. The amniotic fluid is collected using specialized syringes and placed in secure screw-top tubes to maintain the integrity of the sample. Alternatively, chorionic villus sampling (CVS) may be performed, where care is taken to remove any blood clots under sterile conditions before placing the specimen in the appropriate containers. Once collected, these samples are transported to a laboratory in a culture medium, where the cells are cultured to facilitate genetic testing and chromosome analysis. This procedure is vital for diagnosing genetic conditions and guiding patient management.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure described by CPT® Code 88235 is indicated for the evaluation of non-neoplastic disorders, which may include the following conditions:
The procedure for CPT® Code 88235 involves several critical steps to ensure the successful culture of amniotic fluid or chorionic villus cells:
After the procedure, the cultured cells are monitored for growth and division, which is necessary for subsequent chromosome analysis. The laboratory will prepare the cells for analysis, which may include staining and preparing slides for microscopic examination. The results of the chromosome analysis will provide critical information regarding the presence of any genetic abnormalities or conditions. It is important for healthcare providers to communicate the results to the patient and discuss any further steps or interventions that may be necessary based on the findings.
| Short Descr | TISSUE CULTURE PLACENTA | Medium Descr | TISS CUL NON-NEO DISORDERS AMNIOTIC/CHORNC CELLS | Long Descr | Tissue culture for non-neoplastic disorders; amniotic fluid or chorionic villus cells | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 2 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2011-01-01 | Changed | Short description changed. |
| Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.